Literature DB >> 9736048

Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.

A K Charles1, K W Brown, P J Berry.   

Abstract

Nephrogenic rests are precursor lesions associated with about 40% of Wilms' tumors. This study identifies genetic steps occurring in the development of Wilms' tumor. Thirty-four Wilms' tumors with nephrogenic rests and/or areas of anaplasia were microdissected from paraffin sections to determine whether and at what stage loss of heterozygosity (LOH) occurred, using polymerase chain reaction-based polymorphic markers at 11p13, 11p15, and 16q. LOH at these loci have been identified in Wilms' tumors and are associated with identified or putative tumor suppressor genes. Three cystic nephromas/cystic partially differentiated nephroblastomas were also examined. LOH was detected in six cases at 11p13 and in six cases at 11p15, and two of these cases had LOH at both loci. All intralobar rests showing LOH also showed LOH in the tumor. A case with a small perilobar rest showed LOH of 11p13 only in the tumor. Five cases showing LOH at 16q were identified (this was identified only in the tumor, and not in the associated rest), and three of these had recurrence of the tumor. Two cases had a WT1 mutation (one germline and the other somatic), as well as LOH in both the intralobar rest and the tumor. A cystic partially differentiated nephroblastoma showed loss at 11p13 and 11p15, as well as at 16q. This study suggests that LOH at 11p13 and 11p15 and WT1 mutations are early events but that LOH at 16q occurs late in the pathogenesis of Wilms' tumor. Intralobar and perilobar nephrogenic rests are known to have different biological behaviors, and this study suggests that they are genetically different. A multistep model of Wilms' tumor pathogenesis is supported by these findings.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736048      PMCID: PMC1853014          DOI: 10.1016/S0002-9440(10)65641-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  59 in total

Review 1.  Dominant negative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome--proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development.

Authors:  N D Hastie
Journal:  Hum Mol Genet       Date:  1992-08       Impact factor: 6.150

2.  Nephrogenic rest and mesoblastic nephroma.

Authors:  A Charles
Journal:  Pediatr Pathol Lab Med       Date:  1996 Jul-Aug

Review 3.  The genetics of Wilms' tumor--a case of disrupted development.

Authors:  N D Hastie
Journal:  Annu Rev Genet       Date:  1994       Impact factor: 16.830

Review 4.  Beckwith-Wiedemann syndrome.

Authors:  M Elliott; E R Maher
Journal:  J Med Genet       Date:  1994-07       Impact factor: 6.318

5.  Recurrent renal cell carcinoma arising in Wilms' tumor.

Authors:  W C Allsbrook; W C Boswell; H Takahashi; C G Pantazis; C G Howell; J E Martinez; J R Beck
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

6.  Multilocular cyst of the kidney (cystic nephroma) and cystic, partially differentiated nephroblastoma. Terminology and criteria for diagnosis.

Authors:  V V Joshi; J B Beckwith
Journal:  Cancer       Date:  1989-07-15       Impact factor: 6.860

7.  Familial Wilms' tumor: a descriptive study.

Authors:  N E Breslow; J Olson; J Moksness; J B Beckwith; P Grundy
Journal:  Med Pediatr Oncol       Date:  1996-11

8.  Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome.

Authors:  P N Baird; A Santos; N Groves; L Jadresic; J K Cowell
Journal:  Hum Mol Genet       Date:  1992-08       Impact factor: 6.150

9.  Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome.

Authors:  P N Baird; N Groves; D A Haber; D E Housman; J K Cowell
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

Review 10.  Screening for Wilms tumor in high-risk individuals.

Authors:  C L Clericuzio; C Johnson
Journal:  Hematol Oncol Clin North Am       Date:  1995-12       Impact factor: 3.722

View more
  20 in total

1.  Glypican 3 overexpression in primary and metastatic Wilms tumors.

Authors:  Maria Tretiakova; Debra L Zynger; Chunyan Luan; Nicole K Andeen; Laura S Finn; Masha Kocherginsky; Bin T Teh; Ximing J Yang
Journal:  Virchows Arch       Date:  2014-11-04       Impact factor: 4.064

2.  Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumors.

Authors:  Raisa Vuononvirta; Neil J Sebire; Anthony R Dallosso; Jorge S Reis-Filho; Richard D Williams; Alan Mackay; Kerry Fenwick; Anita Grigoriadis; Alan Ashworth; Kathy Pritchard-Jones; Keith W Brown; Gordan M Vujanic; Chris Jones
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

3.  Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.

Authors:  Ryuji Fukuzawa; Rosemary W Heathcott; Helen E More; Anthony E Reeve
Journal:  J Clin Pathol       Date:  2006-12-15       Impact factor: 3.411

4.  Loss of heterozygosity at 11p13 and 11p15 in Wilms tumor: a study of 22 cases from India.

Authors:  Elanthenral Sigamani; Mohammad Nahidul Wari; Venkateswaran K Iyer; Sandeep Agarwala; Arundhati Sharma; Sameer Bakhshi; Amit Dinda
Journal:  Pediatr Surg Int       Date:  2013-01-05       Impact factor: 1.827

5.  Paediatrics: Integrating genomics to dig deeper into Wilms tumour biology.

Authors:  William Mifsud; Kathy Pritchard-Jones
Journal:  Nat Rev Urol       Date:  2017-10-25       Impact factor: 14.432

6.  Nephroblastomatosis and loss of WT1 expression associated with trisomy 13.

Authors:  Frank Traub; Karin Sickmann; Mathewos Tessema; Ludwig Wilkens; Hans H Kreipe; Kenji Kamino
Journal:  Virchows Arch       Date:  2005-09-22       Impact factor: 4.064

Review 7.  A causal mechanism for childhood acute lymphoblastic leukaemia.

Authors:  Mel Greaves
Journal:  Nat Rev Cancer       Date:  2018-08       Impact factor: 60.716

8.  WNT5A is regulated by PAX2 and may be involved in blastemal predominant Wilms tumorigenesis.

Authors:  Yahya Tamimi; Usukuma Ekuere; Nicholas Laughton; Paul Grundy
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

9.  KIT, PDGFRalpha and EGFR analysis in nephroblastoma.

Authors:  Sylvia C Wetli; Ivo Leuschner; Dieter Harms; Alex Rufle; Anja Foerster; Michel Bihl; Norbert Graf; Roikos Furtwaengler; Michael Paulussen; Jakob Briner; Charalampos Aslanidis; Gerd Schmitz; Luigi Tornillo; Michael J Mihatsch; Inti Zlobec; Elisabeth Bruder
Journal:  Virchows Arch       Date:  2008-05-14       Impact factor: 4.064

10.  Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor.

Authors:  Anthony R Dallosso; Anne L Hancock; Marianna Szemes; Kim Moorwood; Laxmi Chilukamarri; Hsin-Hao Tsai; Abby Sarkar; Jonathan Barasch; Raisa Vuononvirta; Chris Jones; Kathy Pritchard-Jones; Brigitte Royer-Pokora; Sean Bong Lee; Ceris Owen; Sally Malik; Yi Feng; Marcus Frank; Andrew Ward; Keith W Brown; Karim Malik
Journal:  PLoS Genet       Date:  2009-11-26       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.